Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Lessons Learned

Sidney Zisook, MD; Krauz Ganadjian, MD; Christine Moutier, MD; Richard Prather, MD; and Sanjai Rao, MD

Published: July 31, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sequenced Treatment Alternatives toRelieve Depression (STAR*D), the largestprospective, randomized antidepressanttreatment trial to date in outpatients withmajor depressive disorder (MDD) recruitedfrom real-world clinical settings, enrolling4011 outpatients aged 18 to 75 years withnonpsychotic MDD. Designed to determinewhich treatments are most effective afternonremission or intolerance to an initial selectiveserotonin reuptake inhibitor (SSRI),or to any of a series of subsequent randomizedtreatments, STAR*D was conductedin 18 primary and 23 psychiatric care settingsacross the United States. This reviewsummarizes unique features of the study,initial remission rates and associated participantcharacteristics, remission rates forsubsequent treatment steps, relapse ratesduring follow-up, and clinical implications.’ ‹

Volume: 69

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500...

Read More...